Kittens receive a standard set of core vaccines against feline panleukopenia virus (FPV), feline herpesvirus-1 (FHV-1), and feline calicivirus (FCV), typically combined in a single injection often called the FVRCP shot. Rabies vaccination is also core in most regions. Depending on lifestyle and risk, a kitten may also get non-core vaccines for feline leukemia virus (FeLV) and occasionally other pathogens. The schedule usually begins around six to eight weeks of age, with boosters every two to four weeks until the kitten is at least 16 weeks old, followed by a one-year booster.
Core Vaccines Every Kitten Needs
Veterinary guidelines from both the AAHA/AAFP and the WSAVA classify certain vaccines as “core,” meaning every cat should receive them regardless of whether the cat lives indoors, outdoors, or somewhere in between.1PubMed Central. 2020 AAHA/AAFP Feline Vaccination Guidelines The three core diseases covered by the FVRCP combination are panleukopenia, herpesvirus, and calicivirus. Rabies rounds out the core list, though it is given as a separate injection.
Panleukopenia is often called “feline distemper,” though it is unrelated to canine distemper. It is caused by a parvovirus that attacks rapidly dividing cells, especially in the gut and bone marrow. In unvaccinated kittens, it can be lethal. Feline herpesvirus-1 and feline calicivirus are the two main causes of upper respiratory disease in cats, producing sneezing, nasal discharge, eye ulcers, and oral ulcers. These viruses are highly contagious in shelters and multi-cat households, and herpesvirus establishes lifelong latent infection. Vaccination does not always prevent infection entirely, but it dramatically reduces the severity of symptoms and viral shedding.
Rabies vaccination is required by law in many jurisdictions and is given as a separate injection, typically starting at 12 to 16 weeks of age. A single dose of rabies vaccine induces long-lasting immunity, but local regulations often call for a booster one year later and then every one to three years depending on the product used.2PubMed Central. Feline rabies. ABCD guidelines on prevention and management
The Typical Kitten Vaccination Schedule
Most veterinarians begin the FVRCP series when a kitten is around six to eight weeks old, then give booster doses every two to four weeks. The critical detail is when the series ends: the final dose should be given at 16 weeks of age or later.3PubMed Central. WSAVA Guidelines for the vaccination of dogs and cats That final shot matters more than any of the earlier ones, because it is the dose most likely to reach a kitten whose maternal antibodies have finally cleared out of the way. A booster is then recommended 12 months after that last kitten dose.
A typical timeline looks roughly like this:
- 6–8 weeks: First FVRCP dose
- 10–12 weeks: Second FVRCP dose; first FeLV dose if recommended
- 14–16 weeks: Third FVRCP dose; second FeLV dose; rabies vaccine
- Around 1 year: FVRCP booster, rabies booster, FeLV booster if applicable
After the one-year boosters, adult cats on a standard schedule typically receive FVRCP every three years and rabies according to local law. Indoor-only cats with stable households and no new cat introductions can sometimes extend those intervals in consultation with their vet, while outdoor cats or those in shelters may need more frequent protection.
Why the Series Takes So Many Doses
Kittens are not getting repeat shots because the first one “didn’t work.” The repeated doses exist because of maternal antibodies. When a queen (mother cat) has immunity to a disease, she passes protective antibodies to her kittens through colostrum in the first day or two of life. Those maternal antibodies shield the kitten during its earliest, most vulnerable weeks, but they also block the kitten’s own immune system from responding to a vaccine.4PubMed Central. Vaccination and Antibody Testing in Cats
The problem is that maternal antibody levels fade at different rates in different kittens. One kitten in a litter might lose its maternal protection by eight weeks, while a littermate still has enough floating around at 14 weeks to neutralize a vaccine dose. Vaccination can only trigger the kitten’s own immune response once maternal antibodies have dropped below a certain threshold.5PubMed Central. Effects of maternally-derived antibodies on serologic responses to vaccination in kittens By giving doses every few weeks across a window, the vet ensures that at least one dose lands during the gap after maternal antibodies have faded but before the kitten encounters a pathogen in the real world.
This is not a minor effect. In one field study of kittens vaccinated against panleukopenia, more than a third failed to develop their own antibodies despite receiving a full three-dose series, largely because of lingering maternal antibody interference.6PubMed Central. Vaccination against Feline Panleukopenia: implications from a field study in kittens That result underscores why the final dose at or after 16 weeks matters so much: by that age, nearly all kittens have lost enough maternal protection for the vaccine to take hold.
How Maternal Antibodies Actually Interfere
The interference is not just a single mechanism. Maternal antibodies essentially work against the vaccine in several overlapping ways. They physically coat the vaccine’s target proteins so the kitten’s own immune cells cannot recognize them. They also form complexes with the vaccine antigens that send inhibitory signals to the kitten’s B cells, preventing antibody production. And by neutralizing the vaccine antigens before the kitten’s antigen-presenting cells can process them properly, maternal antibodies reduce T cell activation as well.7Scientific Reports. Evaluating triple inactivated vaccine-induced immunity from a large-scale study in feline population The upshot is that vaccinating too early is essentially wasted, while vaccinating too late leaves a dangerous gap. The multi-dose series splits the difference.
Non-Core Vaccines and When They Apply
Beyond the FVRCP and rabies shots, your vet may recommend additional vaccines based on your kitten’s expected lifestyle and risk exposure. The most common non-core vaccine for kittens is for feline leukemia virus.
Feline Leukemia Virus (FeLV)
FeLV is spread through close contact between cats, mainly saliva, mutual grooming, and shared food bowls. It can cause immunosuppression, anemia, and lymphoma. The AAHA/AAFP guidelines recommend FeLV vaccination for all kittens during their initial series, since a kitten’s future lifestyle is hard to predict. The primary series is usually two doses given three to four weeks apart, starting around eight to nine weeks of age. Recent research shows a clear booster effect: antibody levels measured after two doses are significantly higher than after one dose alone.8PubMed Central. Antibody responses to feline leukaemia vaccination: exploring the effect of sex, boosting schedule, site of administration and vaccine type
Interestingly, that same research found that female kittens produced roughly 1.6 times higher antibody concentrations against FeLV than males. The reason is not entirely clear, but it is a reminder that vaccine responses are not identical across individuals. After the initial kitten series, whether to continue FeLV boosters into adulthood depends on risk: cats that go outdoors or live with FeLV-positive housemates should continue, while strictly indoor cats in FeLV-free households can often stop.
Chlamydia and Bordetella
Chlamydia felis causes conjunctivitis (eye inflammation) in cats, and a vaccine exists primarily for multi-cat environments where the bacterium circulates. The vaccine reduces clinical signs but does not fully prevent shedding of the organism, so vaccinated cats can still pass it along.9PubMed Central. Efficacy of a new inactivated Chlamydophila felis vaccine in experimentally-infected cats Bordetella bronchiseptica, one of the pathogens behind kennel cough in dogs, can also cause respiratory illness in cats, particularly in crowded shelter settings. An intranasal vaccine is available for cats, though it is used less commonly than the FVRCP combination.
One interesting finding about intranasal vaccines: cats that received an intranasal FHV-1/FCV vaccine showed reduced illness even when challenged with Bordetella, an organism not contained in the vaccine.10PubMed Central. Efficacy of intranasal administration of a modified live feline herpesvirus 1 and feline calicivirus vaccine against disease caused by Bordetella bronchiseptica after experimental challenge This nonspecific immune stimulation from intranasal vaccination may offer a brief window of broader respiratory protection, particularly useful in shelters where kittens encounter many pathogens at once.
Testing Before Vaccination
Before starting a vaccination program, especially the FeLV vaccine, your vet should test the kitten for both FeLV and feline immunodeficiency virus (FIV). Current guidelines recommend testing as soon as possible after acquiring a new kitten, after any exposure to a cat of unknown infection status, and before vaccinating against FeLV or FIV.11PubMed Central. 2020 AAFP Feline Retrovirus Testing and Management Guidelines A kitten that is already FeLV-positive will not benefit from FeLV vaccination and needs a different management plan. Testing is a simple in-clinic blood test that takes about 10 minutes.
FIV-positive kittens can still receive core vaccines and generally should, since their compromised immune systems make them more vulnerable to the diseases those vaccines protect against. But the vaccination strategy and ongoing monitoring will differ from a healthy kitten’s plan, so knowing the retrovirus status up front shapes the entire approach.
Modified Live Versus Inactivated Vaccines
Kitten vaccines come in two broad types. Modified live vaccines (MLV) contain a weakened version of the virus that replicates briefly in the kitten’s body, triggering a strong immune response. Inactivated (killed) vaccines contain virus that cannot replicate and usually include an adjuvant, a chemical additive that boosts the immune response. Both approaches work, and in one recent study of panleukopenia vaccination, the proportion of kittens that reached protective antibody levels was the same regardless of whether they received the MLV or inactivated product, even though the MLV group achieved higher raw antibody levels.12PubMed Central. Antibody responses to inactivated (adjuvanted) and attenuated (non-adjuvanted) feline panleukopaenia virus vaccination, including in different injection sites
The choice between the two is not purely about efficacy; it also matters for safety. Adjuvanted vaccines have been associated with a rare but serious complication called feline injection-site sarcoma, a type of tumor that develops at the injection site. Current guidelines recommend using non-adjuvanted, modified live, or recombinant vaccines in preference to adjuvanted ones when possible.13PubMed Central. Feline injection-site sarcoma: ABCD guidelines on prevention and management This is also why vets have shifted where they give injections. The old default was between the shoulder blades, but current guidance says to avoid that area because surgery there is difficult if a sarcoma develops. Instead, injections are given lower on the limbs or even the tail, where surgical removal would be more straightforward if ever needed.
How Quickly Do the Vaccines Start Working?
After vaccination, protection does not appear instantaneously, but it comes on faster than many people expect. In kittens vaccinated with a non-adjuvanted combination vaccine, the onset of protection against panleukopenia, herpesvirus, and calicivirus was detectable within seven days of a single dose. Kittens challenged with these viruses one week after vaccination showed significantly less illness and lower viral shedding than unvaccinated controls, and that level of protection was comparable to kittens challenged three to four weeks after vaccination.14PubMed. Onset of immunity in kittens after vaccination with a non-adjuvanted vaccine against feline panleucopenia, feline calicivirus and feline herpesvirus
This is particularly relevant for shelters, where kittens are often vaccinated on intake and immediately housed near other animals. Knowing that meaningful protection begins within a week helps shelters make informed decisions about quarantine periods and group housing. For pet owners, it means a freshly vaccinated kitten is not completely defenseless while waiting for the next booster, though full protection is not established until the series is complete.
Kittens With Unknown Vaccination History
Adopted strays, rescued kittens, and cats from sources where records are unavailable present a common puzzle. The safest approach is to treat them as unvaccinated and begin the full series. A kitten that has already received some doses and gets an extra round is not at meaningful risk from “over-vaccination” with core vaccines. The immune system simply meets an antigen it already recognizes and mounts a booster response.
The WSAVA guidelines address this scenario and recommend starting the core series at whatever age the kitten is first seen, then following the standard interval schedule with the final dose at 16 weeks or later.3PubMed Central. WSAVA Guidelines for the vaccination of dogs and cats For older kittens or young adults arriving with no records, two doses of FVRCP given two to four weeks apart, followed by a booster a year later, is generally sufficient. Rabies follows local legal requirements but is typically a single dose with a one-year booster.
For shelter kittens specifically, rabies vaccination may happen earlier than the traditional 12-week mark. A small study found that kittens vaccinated against rabies at approximately nine weeks of age, who had no detectable maternal rabies antibodies, produced a robust immune response within 28 days.15Journal of Shelter Medicine and Community Animal Health. Response to Rabies Vaccine in Kittens Under 12 Weeks of Age This has practical implications for shelters that sterilize and adopt out kittens at younger ages, since sending a kitten home with at least one rabies dose is better than hoping the new owner follows up.
Common Side Effects
Most kittens tolerate vaccination well. Mild side effects can include brief lethargy, a slight fever, reduced appetite for a day, or a small lump at the injection site that resolves within a few weeks. Sneezing for a day or two is common after intranasal vaccines, since the vaccine is literally delivered into the nose. These are all normal immune responses and not cause for alarm.
Severe reactions like facial swelling, vomiting, difficulty breathing, or collapse are rare but constitute emergencies. If you see any of these signs within a few hours of vaccination, contact your vet immediately. The risk of a serious reaction is far lower than the risk of the diseases themselves, which is why vaccination remains a standard recommendation for every kitten.
The more subtle long-term concern is injection-site sarcoma, discussed earlier. This tumor is rare, estimated to occur on the order of one in every several thousand to tens of thousands of injections, but it is aggressive when it does appear. The shift to limb and tail injection sites, combined with the preference for non-adjuvanted vaccines, reflects the veterinary community’s effort to minimize this risk without forgoing the enormous benefit of vaccination.13PubMed Central. Feline injection-site sarcoma: ABCD guidelines on prevention and management
Indoor-Only Kittens Still Need Vaccines
A common misconception is that a kitten destined for a strictly indoor life can skip vaccination entirely. The core vaccines remain recommended regardless of lifestyle.1PubMed Central. 2020 AAHA/AAFP Feline Vaccination Guidelines Panleukopenia virus is extraordinarily hardy and can survive in the environment for months to years. You can track it into your home on shoes or clothing without knowing it. Herpesvirus and calicivirus, while less environmentally stable, can arrive on your hands or on a new cat. Rabies vaccination is a legal requirement in most places regardless of lifestyle, and even “indoor” cats occasionally escape.
Where indoor status does make a difference is with the non-core vaccines. A kitten that will never encounter unfamiliar cats likely does not need ongoing FeLV boosters after the initial kitten series. Chlamydia and Bordetella vaccines are almost never recommended for single indoor cats. The distinction between core and non-core is specifically designed to let vets tailor the protocol without leaving any cat unprotected against the most dangerous, most transmissible diseases.
Emerging Vaccine Research in Cats
Traditional injectable vaccines are the mainstay, but researchers are exploring new platforms. One group recently developed an oral vaccine against panleukopenia using an engineered strain of Lactobacillus, a bacterium that naturally colonizes the gut. In kittens, 30 days of oral dosing produced high levels of neutralizing antibodies and significant protection against lethal FPV challenge.16PubMed. Development of a recombinant Lactobacillus plantarum oral vaccine expressing VP2 protein for preventing feline panleukopenia virus An oral vaccine that does not require injection, cold-chain storage, or a trained vaccinator could be transformative for feral cat colonies and under-resourced shelters.
Similarly, recombinant viral vector vaccines are being developed that use a weakened herpesvirus as a carrier to deliver calicivirus proteins, potentially replacing both the FHV and FCV components in a single engineered virus.17PubMed. The recombinant feline herpesvirus 1 expressing feline Calicivirus VP1 protein is safe and effective in cats These are still in experimental stages, but they represent the general direction feline vaccinology is heading: fewer injections, fewer adjuvants, and more targeted immune stimulation. For the average kitten owner today, the practical takeaway is that the tools are likely to improve over the coming years, but the current vaccines already do an excellent job when given on schedule.